We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. Targeting MHC-I molecules for cancer: function, mechanism, and therapeutic prospects

    The molecules of Major histocompatibility class I (MHC-I) load peptides and present them on the cell surface, which provided the immune system with...

    **angyu Wu, Tianhang Li, ... Rong Yang in Molecular Cancer
    Article Open access 02 December 2023
  2. LATS1/2 loss promote tumor immune evasion in endometrial cancer through downregulating MHC-I expression

    Background

    LATS1/2 are frequently mutated and down-regulated in endometrial cancer (EC), but the contributions of LATS1/2 in EC progression remains...

    Qianlan Yang, Zehen Lv, ... ** Wan in Journal of Experimental & Clinical Cancer Research
    Article Open access 21 February 2024
  3. TIMP-1 is an activator of MHC-I expression in myeloid dendritic cells with implications for tumor immunogenicity

    Immune checkpoint therapies (ICT) for advanced solid tumors mark a new milestone in cancer therapy. Yet their efficacy is often limited by poor...

    Miriam Langguth, Eleftheria Maranou, ... Carlos R. Figueiredo in Genes & Immunity
    Article Open access 22 May 2024
  4. Tumor-associated macrophage-derived exosomes LINC01592 induce the immune escape of esophageal cancer by decreasing MHC-I surface expression

    Background

    TAMs (tumor-associated macrophages) infiltration promotes the progression of esophageal cancer (EC). However, the underlying mechanisms...

    **nwei Qiao, Zaixing Cheng, ... **song Li in Journal of Experimental & Clinical Cancer Research
    Article Open access 02 November 2023
  5. Pharmacologic inhibition of IL11/STAT3 signaling increases MHC-I expression and T cell infiltration

    Background

    Recent studies have discovered an emerging role of IL11 in various colitis-associated cancers, suggesting that IL11 mainly promotes tumor...

    Wenjun **ong, Yuehong Chen, ... Tingyu Mou in Journal of Translational Medicine
    Article Open access 26 June 2023
  6. Blockade of histamine receptor H1 augments immune checkpoint therapy by enhancing MHC-I expression in pancreatic cancer cells

    Background

    Although immune checkpoint blockade (ICB) therapy has proven to be extremely effective at managing certain cancers, its efficacy in...

    **Shan Zhong, Kohei Nakata, ... Masafumi Nakamura in Journal of Experimental & Clinical Cancer Research
    Article Open access 08 May 2024
  7. Designing High Binding Affinity Peptides for MHC Class I Using MAM: An In Silico Approach

    The availability of extensive MHC-peptide binding data has boosted machine learning-based approaches for predicting binding affinity and identifying...
    Yu Wei Zhang in HLA Ty**
    Protocol 2024
  8. The minor chicken class I gene BF1 is deleted between short imperfect direct repeats in the B14 and typical B15 major histocompatibility complex (MHC) haplotypes

    The chicken major histocompatibility complex (MHC, also known as the BF-BL region of the B locus) is notably small and simple with few genes, most of...

    Nicolas I. E. Rocos, Felicity J. Coulter, ... Jim Kaufman in Immunogenetics
    Article Open access 05 July 2023
  9. MHC class I links with severe pathogenicity in C57BL/6N mice infected with SARS-CoV-2/BMA8

    Background

    The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes non-symptomatic infection, mild influenza-like symptoms to...

    Tian Qin, Beilei Shen, ... Yuwei Gao in Virology Journal
    Article Open access 20 April 2023
  10. Unleashing T cell anti-tumor immunity: new potential for 5-Nonloxytryptamine as an agent mediating MHC-I upregulation in tumors

    Background

    New therapies are urgently needed in melanoma, particularly in late-stage patients not responsive to immunotherapies and kinase inhibitors....

    Paweł Stachura, Wei Liu, ... Aleksandra A. Pandyra in Molecular Cancer
    Article Open access 15 August 2023
  11. The antigen recognition portion of African buffalo class I MHC is highly polymorphic, consistent with a complex pathogen challenge environment, and the 3’ region suggests distinct haplotype configurations

    African buffalo ( Syncerus caffer) have been distinct from the Auroch lineage leading to domestic cattle for 5 million years, and are reservoirs of...

    Isaiah Obara, Ard Nijhof, ... Richard Bishop in Immunogenetics
    Article Open access 13 December 2022
  12. Non-canonical antigens are the largest fraction of peptides presented by MHC class I in mismatch repair deficient murine colorectal cancer

    Background

    Immunotherapy based on checkpoint inhibitors is highly effective in mismatch repair deficient (MMRd) colorectal cancer (CRC). These tumors...

    Giuseppe Rospo, Rosaria Chilà, ... Alberto Bardelli in Genome Medicine
    Article Open access 19 January 2024
  13. Epithelial cells remove precancerous cells by cell competition via MHC class I–LILRB3 interaction

    Epithelial cells have an ability termed ‘cell competition’, which is an immune surveillance-like function that extrudes precancerous cells from the...

    Shiyu Ayukawa, Nagisa Kamoshita, ... Takeshi Maruyama in Nature Immunology
    Article 22 October 2021
  14. Identification of human MHC-I HPV18 E6/E7-specific CD8 + T cell epitopes and generation of an HPV18 E6/E7-expressing adenosquamous carcinoma in HLA-A2 transgenic mice

    Background

    Human Papillomavirus type 18 (HPV18) is a high-risk HPV that is commonly associated with cervical cancer. HPV18 oncogenes E6 and E7 are...

    Shiwen Peng, Deyin **ng, ... T.-C. Wu in Journal of Biomedical Science
    Article Open access 12 October 2022
  15. Adaptive meets innate: CD8+ T cells kill MHC-I-negative tumour cells

    Bas W. A. Peeters, Geraldine M. Gillespie in Nature Reviews Immunology
    Article 29 March 2023
  16. Neuronal ApoE upregulates MHC-I expression to drive selective neurodegeneration in Alzheimer’s disease

    Selective neurodegeneration is a critical causal factor in Alzheimer’s disease (AD); however, the mechanisms that lead some neurons to perish,...

    Kelly A. Zalocusky, Ramsey Najm, ... Yadong Huang in Nature Neuroscience
    Article 06 May 2021
  17. Digging deeper into the immunopeptidome: characterization of post-translationally modified peptides presented by MHC I

    Peptides presented by MHC molecules on the cell surface, or the immunopeptidome, play an important role in the adaptive arm of the immune response....

    Kiran K. Mangalaparthi, Anil K. Madugundu, ... Akhilesh Pandey in Journal of Proteins and Proteomics
    Article Open access 04 June 2021
  18. Antibody-mediated delivery of a viral MHC-I epitope into the cytosol of target tumor cells repurposes virus-specific CD8+ T cells for cancer immunotherapy

    Background

    Redirecting pre-existing virus-specific cytotoxic CD8 + T lymphocytes (CTLs) to tumors by simulating a viral infection of the tumor cells...

    Keunok Jung, Min-Jeong Son, ... Yong-Sung Kim in Molecular Cancer
    Article Open access 22 April 2022
  19. The MHC class I MICA gene is a histocompatibility antigen in kidney transplantation

    The identity of histocompatibility loci, besides human leukocyte antigen ( HLA ), remains elusive. The major histocompatibility complex (MHC) class I MICA...

    Raphael Carapito, Ismail Aouadi, ... Seiamak Bahram in Nature Medicine
    Article Open access 14 March 2022
Did you find what you were looking for? Share feedback.